Comments

Vera Therapeutics

VERANASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$35.00
0.351.01%
Pre-Market: Jul 19, 5:30 PM EDT
15 minutes delayed
Vera Therapeutics (VERA) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$68.00
Lowest Price Target1
$6.00
Consensus Price Target1
$35.22

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

Vera Therapeutics (NASDAQ:VERA) Stock, Analyst Ratings, Price Targets, Forecasts

Vera Therapeutics Inc has a consensus price target of $35.22 based on the ratings of 10 analysts. The high is $68 issued by Raymond James on May 10, 2024. The low is $6 issued by Jefferies on January 4, 2023. The 3 most-recent analyst ratings were released by JP Morgan, Raymond James, and Guggenheim on May 31, 2024, May 10, 2024, and April 5, 2024, respectively. With an average price target of $63 between JP Morgan, Raymond James, and Guggenheim, there's an implied 80.00% upside for Vera Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
1
Jan
1
Mar
0
0
0
0
Apr
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

JP Morgan
Raymond James
Guggenheim
Wedbush
Oppenheimer

1calculated from analyst ratings

Analyst Ratings for Vera Therapeutics

Buy NowGet Alert
05/31/2024Buy Now85.71%JP Morgan
Anupam Rama
$60 → $65MaintainsOverweightGet Alert
05/10/2024Buy Now94.29%Raymond James
Steven Seedhouse
$57 → $68MaintainsStrong BuyGet Alert
04/05/2024Buy Now60%Guggenheim
Vamil Divan
 → $56ReiteratesBuy → BuyGet Alert
03/27/2024Buy Now60%Guggenheim
Vamil Divan
$27 → $56MaintainsBuyGet Alert
03/21/2024Buy Now-2.86%Wedbush
Laura Chico
$21 → $34MaintainsNeutralGet Alert
01/26/2024Buy Now-40%Wedbush
Laura Chico
$16 → $21MaintainsNeutralGet Alert
01/26/2024Buy Now5.71%Raymond James
Steven Seedhouse
$29 → $37UpgradeOutperform → Strong BuyGet Alert
01/25/2024Buy Now-25.71%Oppenheimer
Justin Kim
 → $26Initiates → OutperformGet Alert
01/08/2024Buy Now—Cantor Fitzgerald
Pete Stavropoulos
—Initiates → OverweightGet Alert
12/27/2023Buy Now-28.57%HC Wainwright & Co.
Ed Arce
 → $25ReiteratesBuy → BuyGet Alert
12/18/2023Buy Now-17.14%Raymond James
Steven Seedhouse
 → $29Initiates → OutperformGet Alert
11/30/2023Buy Now-37.14%JP Morgan
Anupam Rama
$25 → $22MaintainsOverweightGet Alert
11/10/2023Buy Now-25.71%Jefferies
Farzin Haque
$18 → $26UpgradeHold → BuyGet Alert
09/26/2023Buy Now-28.57%HC Wainwright & Co.
Ed Arce
$10 → $25MaintainsBuyGet Alert
08/16/2023Buy Now-22.86%Guggenheim
Vamil Divan
 → $27Initiates → BuyGet Alert
08/11/2023Buy Now-54.29%Wedbush
Laura Chico
$12 → $16MaintainsNeutralGet Alert
06/08/2023Buy Now-71.43%HC Wainwright & Co.
Ed Arce
 → $10ReiteratesBuy → BuyGet Alert
05/12/2023Buy Now-71.43%HC Wainwright & Co.
Ed Arce
$11 → $10MaintainsBuyGet Alert
05/12/2023Buy Now-74.29%Wedbush
Laura Chico
$6 → $9MaintainsNeutralGet Alert
04/12/2023Buy Now-37.14%JP Morgan
Anupam Rama
$38 → $22MaintainsOverweightGet Alert
03/29/2023Buy Now-68.57%HC Wainwright & Co.—$15 → $11MaintainsBuyGet Alert
01/04/2023Buy Now-82.86%Jefferies
Maury Raycroft
$32 → $6DowngradeBuy → HoldGet Alert
01/04/2023Buy Now-77.14%Wedbush
Laura Chico
 → $8DowngradeOutperform → NeutralGet Alert
01/04/2023Buy Now-57.14%HC Wainwright & Co.
Ed Arce
$36 → $15MaintainsBuyGet Alert
11/18/2022Buy Now8.57%JP Morgan
Anupam Rama
$35 → $38MaintainsOverweightGet Alert
08/22/2022Buy Now2.86%HC Wainwright & Co.
Ed Arce
$35 → $36MaintainsBuyGet Alert
07/12/2022Buy Now—JP Morgan
Anupam Rama
 → $35Initiates → OverweightGet Alert
05/02/2022Buy Now—HC Wainwright & Co.
Ed Arce
 → $35Initiates → BuyGet Alert
04/19/2022Buy Now-8.57%Wedbush
Laura Chico
 → $32Initiates → OutperformGet Alert

FAQ

Q

What is the target price for Vera Therapeutics (VERA) stock?

A

The latest price target for Vera Therapeutics (NASDAQ:VERA) was reported by JP Morgan on May 31, 2024. The analyst firm set a price target for $65.00 expecting VERA to rise to within 12 months (a possible 85.71% upside). 16 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Vera Therapeutics (VERA)?

A

The latest analyst rating for Vera Therapeutics (NASDAQ:VERA) was provided by JP Morgan, and Vera Therapeutics maintained their overweight rating.

Q

When was the last upgrade for Vera Therapeutics (VERA)?

A

The last upgrade for Vera Therapeutics Inc happened on January 26, 2024 when Raymond James raised their price target to $37. Raymond James previously had an outperform for Vera Therapeutics Inc.

Q

When was the last downgrade for Vera Therapeutics (VERA)?

A

The last downgrade for Vera Therapeutics Inc happened on January 4, 2023 when Jefferies changed their price target from $32 to $6 for Vera Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Vera Therapeutics (VERA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vera Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vera Therapeutics was filed on May 31, 2024 so you should expect the next rating to be made available sometime around May 31, 2025.

Q

Is the Analyst Rating Vera Therapeutics (VERA) correct?

A

While ratings are subjective and will change, the latest Vera Therapeutics (VERA) rating was a maintained with a price target of $60.00 to $65.00. The current price Vera Therapeutics (VERA) is trading at is $35.00, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch